Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Debt / NOTE 2.500% 2/1
-
Market price (% of par)
-
110.53%
-
Total 13F principal
-
$189,113,000
-
Principal change
-
+$1,968,000
-
Total reported market value
-
$209,111,391
-
Number of holders
-
31
-
Value change
-
+$2,799,996
-
Number of buys
-
14
-
Number of sells
-
16
Institutional Holders of AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1 as of Q2 2016
As of 30 Jun 2016,
AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1 was held by
31 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$189,113,000
in principal (par value) of the bond.
The largest 10 bondholders included
STELLIAM INVESTMENT MANAGEMENT, LP, FMR LLC, WOLVERINE ASSET MANAGEMENT LLC, Birch Grove Capital LP, TD ASSET MANAGEMENT INC, CITADEL ADVISORS LLC, CALAMOS ADVISORS LLC, LAZARD ASSET MANAGEMENT LLC, DEERFIELD MANAGEMENT CO, and UBS Group AG.
This page lists
31
institutional bondholders reporting positions
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.